Form 4: SeaStar Medical Director Allan Collins Acquires 4,000 Restricted Stock Units

Director Allan Collins of SeaStar Medical Holding Corp. acquired 4,000 restricted stock units on November 13, 2024, which will vest on June 4, 2025.

Summary

• Allan Collins, a director at SeaStar Medical Holding Corp., was granted 4,000 restricted stock units on November 13, 2024.
• These restricted stock units represent a contingent right to receive one share of ICU common stock each.
• The restricted stock units will vest 100% on June 4, 2025.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of equity compensation, which is generally viewed positively as it aligns director interests with the company's success. There are no negative implications.

Positives

• The grant of restricted stock units to a director aligns their interests with the company's long-term performance.
• The vesting schedule encourages the director's continued service and contribution to the company.

Industry Context

This is a standard practice for companies to grant equity compensation to directors and key personnel to align their interests with shareholders.

Comparison to Industry Standards

• Granting restricted stock units is a common practice among publicly traded companies to incentivize directors and align their interests with shareholders.
• The vesting period of approximately 7 months is within the typical range for such grants.
• Many companies in the biotech and medical device sectors use similar equity-based compensation plans.

Stakeholder Impact

• The grant of restricted stock units to a director is generally positive for shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

restricted stock units, insider trading, SeaStar Medical, ICU, Allan Collins, director, equity compensation, vesting